|
US7029652B2
(en)
*
|
1998-09-16 |
2006-04-18 |
The Regents Of The University Of California |
Method of treating tumors
|
|
US7214687B2
(en)
|
1999-07-14 |
2007-05-08 |
Almirall Ag |
Quinuclidine derivatives and medicinal compositions containing the same
|
|
ES2165768B1
(es)
|
1999-07-14 |
2003-04-01 |
Almirall Prodesfarma Sa |
Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
|
|
GB0019172D0
(en)
|
2000-08-05 |
2000-09-27 |
Glaxo Group Ltd |
Novel compounds
|
|
WO2002012266A1
(en)
|
2000-08-05 |
2002-02-14 |
Glaxo Group Limited |
17.beta.-carbothioate 17.alpha.-arylcarbonyloxyloxy androstane derivative as anti-inflammatory agents
|
|
US6777399B2
(en)
|
2000-08-05 |
2004-08-17 |
Smithkline Beecham Corporation |
Anti-inflammatory androstane derivative compositions
|
|
US20020111363A1
(en)
*
|
2000-10-31 |
2002-08-15 |
Karin Drechsel |
Inhalable formulation of a solution containing a tiotropium salt
|
|
PT1383786E
(pt)
|
2001-04-30 |
2008-12-30 |
Glaxo Group Ltd |
Derivados anti-inflamatórios de éster 17.beta-carbotioato de androstano com um grupo éster ciclíco na posição 17.alfa
|
|
GB2389530B
(en)
|
2002-06-14 |
2007-01-10 |
Cipla Ltd |
Pharmaceutical compositions
|
|
DE10237739A1
(de)
*
|
2002-08-17 |
2004-02-26 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Inhalative Arzneimittel enthaltend ein neues Anticholinergikum in Kombination mit Corticosteroiden und Betamimetika
|
|
US7244742B2
(en)
|
2002-08-17 |
2007-07-17 |
Boehringer Ingelheim Pharma Gmbh & Co Kg |
Pharmaceutical compositions for inhalation containing an anticholinergic, corticosteroid and betamimetic
|
|
US7407955B2
(en)
|
2002-08-21 |
2008-08-05 |
Boehringer Ingelheim Pharma Gmbh & Co., Kg |
8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
|
|
EP2322243A1
(en)
|
2002-08-29 |
2011-05-18 |
Cipla Ltd. |
Pharmaceutical products and compositions comprising formoterol, ciclesonide and tiotropium
|
|
US7056916B2
(en)
|
2002-11-15 |
2006-06-06 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Medicaments for the treatment of chronic obstructive pulmonary disease
|
|
UA83813C2
(ru)
*
|
2002-12-20 |
2008-08-26 |
Бёрингер Ингельхайм Фарма Гмбх & Ко. Кг |
Порошковое лекарственное средство, которое содержит соль тиотропия и ксинафоат салметерола
|
|
EP1651221B1
(en)
*
|
2003-07-28 |
2009-01-14 |
Boehringer Ingelheim International Gmbh |
Medicaments for inhalation comprising betamimetics and an anticholinergic agent
|
|
US20050026948A1
(en)
*
|
2003-07-29 |
2005-02-03 |
Boehringer Ingelheim International Gmbh |
Medicaments for inhalation comprising an anticholinergic and a betamimetic
|
|
US20050026884A1
(en)
*
|
2003-07-31 |
2005-02-03 |
Robinson Cynthia B. |
Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a beta-agonist bronchodilator for treatment of asthma or chronic obstructive pulmonary disease
|
|
DE10345065A1
(de)
*
|
2003-09-26 |
2005-04-14 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Aerosolformulierung für die Inhalation enthaltend ein Anticholinergikum
|
|
US7501426B2
(en)
|
2004-02-18 |
2009-03-10 |
Boehringer Ingelheim International Gmbh |
8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions
|
|
DE102004019539A1
(de)
*
|
2004-04-22 |
2005-11-10 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Arzneimittel zur Behandlung von Atemwegserkrankungen
|
|
AU2005235419B2
(en)
*
|
2004-04-22 |
2010-11-04 |
Boehringer Ingelheim International Gmbh |
Pharmaceutical combinations containing benzoxazine for treating respiratory diseases
|
|
US7220742B2
(en)
|
2004-05-14 |
2007-05-22 |
Boehringer Ingelheim International Gmbh |
Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments
|
|
ATE474601T1
(de)
*
|
2004-05-31 |
2010-08-15 |
Almirall Sa |
Kombinationen mit antimuskarin-wirkstoffen und pde4-hemmern
|
|
ES2257152B1
(es)
*
|
2004-05-31 |
2007-07-01 |
Laboratorios Almirall S.A. |
Combinaciones que comprenden agentes antimuscarinicos y agonistas beta-adrenergicos.
|
|
US20060034776A1
(en)
*
|
2004-08-10 |
2006-02-16 |
Boehringer Ingelheim International Gmbh |
Inhalable medicaments containing a new anticholinergic, corticosteroids, and betamimetics
|
|
DE102004054054A1
(de)
|
2004-11-05 |
2006-05-11 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Verfahren zur Herstellung chiraler 8-(3-Amino-piperidin-1-yl)-xanthine
|
|
DE102004056578A1
(de)
*
|
2004-11-23 |
2006-05-24 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Inhalative Arzneimittel enthaltend ein neues Anticholinergikum, Formoterol und ein Steroid
|
|
DE102004056579A1
(de)
*
|
2004-11-23 |
2006-05-24 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Inhalative Arzneimittel enthaltend ein neues Anticholinergikum, Salmeterol und ein Steroid
|
|
GB0501956D0
(en)
*
|
2005-01-31 |
2005-03-09 |
Arrow Internat |
Nebulizer formulation
|
|
DE102005007654A1
(de)
*
|
2005-02-19 |
2006-08-24 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue langwirksame Betamimetika zur Behandlung von Atemwegserkrankungen
|
|
WO2006094924A2
(en)
*
|
2005-03-09 |
2006-09-14 |
Boehringer Ingelheim International Gmbh |
New pharmaceutical compositions based on anticholinergics and pde 5-inhibitors
|
|
EP2484382A1
(en)
*
|
2005-03-30 |
2012-08-08 |
Schering Corporation |
Medicament comprising a phosphodiesterase IV inhibitor in an inhalable form
|
|
EP1879571A1
(de)
*
|
2005-04-23 |
2008-01-23 |
Boehringer Ingelheim International GmbH |
Arzneimittelkombination für die inhalation enthaltend neben einem anticholinergikum ein betamimetikum und ein steroid
|
|
DE102005035891A1
(de)
|
2005-07-30 |
2007-02-08 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
8-(3-Amino-piperidin-1-yl)-xanthine, deren Herstellung und deren Verwendung als Arzneimittel
|
|
CN101208316B
(zh)
|
2005-08-15 |
2012-05-09 |
贝林格尔·英格海姆国际有限公司 |
制备β-模拟物的方法
|
|
NZ591969A
(en)
*
|
2005-12-21 |
2012-05-25 |
Meda Pharma Gmbh & Co Kg |
Combination of anticholinergics, glucocorticoids, beta2-adrenoceptor agonists, PDE 4 inhibitor and antileukotriene for the treatment of inflammatory diseases
|
|
EP1852108A1
(en)
|
2006-05-04 |
2007-11-07 |
Boehringer Ingelheim Pharma GmbH & Co.KG |
DPP IV inhibitor formulations
|
|
KR101452915B1
(ko)
|
2006-05-04 |
2014-10-21 |
베링거 인겔하임 인터내셔날 게엠베하 |
다형태
|
|
PE20110235A1
(es)
|
2006-05-04 |
2011-04-14 |
Boehringer Ingelheim Int |
Combinaciones farmaceuticas que comprenden linagliptina y metmorfina
|
|
US20110135580A1
(en)
*
|
2006-05-24 |
2011-06-09 |
Boehringer Ingelheim International Gmbh |
Novel Medicament Combinations for the Treatment of Respiratory Diseases
|
|
ES2298049B1
(es)
|
2006-07-21 |
2009-10-20 |
Laboratorios Almirall S.A. |
Procedimiento para fabricar bromuro de 3(r)-(2-hidroxi-2,2-ditien-2-ilacetoxi)-1-(3-fenoxipropil)-1-azoniabiciclo (2.2.2) octano.
|
|
JP2010500318A
(ja)
*
|
2006-08-07 |
2010-01-07 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
呼吸器疾患の治療用医薬組成物
|
|
UY30542A1
(es)
*
|
2006-08-18 |
2008-03-31 |
Boehringer Ingelheim Int |
Formulacion de aerosol para la inhalacion de agonistas beta
|
|
CA2608561A1
(en)
*
|
2007-10-29 |
2009-04-29 |
Carl Paluszkiewicz |
Motorcycle wind deflector accessory support
|
|
EP2100599A1
(en)
|
2008-03-13 |
2009-09-16 |
Laboratorios Almirall, S.A. |
Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
|
|
EP2100598A1
(en)
*
|
2008-03-13 |
2009-09-16 |
Laboratorios Almirall, S.A. |
Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
|
|
PE20091730A1
(es)
|
2008-04-03 |
2009-12-10 |
Boehringer Ingelheim Int |
Formulaciones que comprenden un inhibidor de dpp4
|
|
KR20190016601A
(ko)
|
2008-08-06 |
2019-02-18 |
베링거 인겔하임 인터내셔날 게엠베하 |
메트포르민 요법이 부적합한 환자에서의 당뇨병 치료
|
|
UY32030A
(es)
|
2008-08-06 |
2010-03-26 |
Boehringer Ingelheim Int |
"tratamiento para diabetes en pacientes inapropiados para terapia con metformina"
|
|
CA2736421A1
(en)
|
2008-09-10 |
2010-03-18 |
Boehringer Ingelheim International Gmbh |
Combination therapy for the treatment of diabetes and related conditions
|
|
US20200155558A1
(en)
|
2018-11-20 |
2020-05-21 |
Boehringer Ingelheim International Gmbh |
Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug
|
|
JP2012512848A
(ja)
|
2008-12-23 |
2012-06-07 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
有機化合物の塩の形態
|
|
TW201036975A
(en)
|
2009-01-07 |
2010-10-16 |
Boehringer Ingelheim Int |
Treatment for diabetes in patients with inadequate glycemic control despite metformin therapy
|
|
US8815258B2
(en)
|
2009-05-29 |
2014-08-26 |
Pearl Therapeutics, Inc. |
Compositions, methods and systems for respiratory delivery of two or more active agents
|
|
MX337126B
(es)
|
2009-05-29 |
2016-02-12 |
Pearl Therapeutics Inc |
Administracion respiratoria de agentes activos.
|
|
KR20240090632A
(ko)
|
2009-11-27 |
2024-06-21 |
베링거 인겔하임 인터내셔날 게엠베하 |
리나글립틴과 같은 ｄｐｐ－ｉｖ 억제제를 사용한 유전자형 검사된 당뇨병 환자의 치료
|
|
US8834931B2
(en)
|
2009-12-25 |
2014-09-16 |
Mahmut Bilgic |
Dry powder formulation containing tiotropium for inhalation
|
|
WO2011093812A2
(en)
*
|
2010-01-28 |
2011-08-04 |
Mahmut Bilgic |
Pharmaceutical formulation comprising tiotropium and budesonide in dry powder form
|
|
TR201000622A2
(tr)
*
|
2010-01-28 |
2011-08-22 |
Bi̇lgi̇ç Mahmut |
Tiotropyum içeren farmasötik kombinasyonlar.
|
|
TR201000680A2
(tr)
*
|
2010-01-29 |
2011-08-22 |
B�Lg�� Mahmut |
Tiotropyum, formoterol ve budesonid içeren farmasötik bileşimler
|
|
WO2011093810A2
(en)
*
|
2010-01-28 |
2011-08-04 |
Bilgic Mahmut |
Dry powder pharmaceutical composition comprising tiotropium and mometasone
|
|
WO2011093811A2
(en)
*
|
2010-01-29 |
2011-08-04 |
Mahmut Bilgic |
Pharmaceutical preparations comprising formoterol and fluticasone
|
|
CA3070513C
(en)
|
2010-05-05 |
2023-01-03 |
Boehringer Ingelheim International Gmbh |
A dpp-4 inhibitor for use in treatment of skin-alterations or necrosis
|
|
KR20130093012A
(ko)
|
2010-06-24 |
2013-08-21 |
베링거 인겔하임 인터내셔날 게엠베하 |
당뇨병 요법
|
|
RU2568882C2
(ru)
*
|
2010-07-16 |
2015-11-20 |
Сипла Лимитед |
Фармацевтические композиции
|
|
WO2012010854A1
(en)
|
2010-07-23 |
2012-01-26 |
Cipla Limited |
Inhalation formulations comprising carmoterol in combination with a corticosteroid
|
|
TR201007251A2
(tr)
*
|
2010-09-01 |
2012-03-21 |
Bi̇lgi̇ç Mahmut |
Kalsiyum kanal blokörü formülasyonu.
|
|
RU2642624C2
(ru)
|
2010-10-12 |
2018-01-25 |
Сипла Лимитед |
Фармацевтическая композиция
|
|
AR083878A1
(es)
|
2010-11-15 |
2013-03-27 |
Boehringer Ingelheim Int |
Terapia antidiabetica vasoprotectora y cardioprotectora, linagliptina, metodo de tratamiento
|
|
EP2749283A3
(en)
|
2011-02-17 |
2014-08-20 |
Cipla Limited |
Combination of glycopyrronium and olodaterol
|
|
EP2510928A1
(en)
|
2011-04-15 |
2012-10-17 |
Almirall, S.A. |
Aclidinium for use in improving the quality of sleep in respiratory patients
|
|
DK2731947T3
(en)
|
2011-07-15 |
2019-04-23 |
Boehringer Ingelheim Int |
SUBSTITUTED DIMERIC QUINAZOLINE DERIVATIVE, PREPARATION AND USE thereof IN PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF TYPE I AND TYPE II DIABETES
|
|
GB201200525D0
(en)
*
|
2011-12-19 |
2012-02-29 |
Teva Branded Pharmaceutical Prod R & D Inc |
An inhalable medicament
|
|
EP2819669B1
(de)
|
2012-02-28 |
2021-04-21 |
Boehringer Ingelheim International GmbH |
Neue treibgashaltige tiotropium-formulierung
|
|
US9555001B2
(en)
|
2012-03-07 |
2017-01-31 |
Boehringer Ingelheim International Gmbh |
Pharmaceutical composition and uses thereof
|
|
WO2013171167A1
(en)
|
2012-05-14 |
2013-11-21 |
Boehringer Ingelheim International Gmbh |
A xanthine derivative as dpp -4 inhibitor for use in the treatment of podocytes related disorders and/or nephrotic syndrome
|
|
WO2013171166A1
(en)
|
2012-05-14 |
2013-11-21 |
Boehringer Ingelheim International Gmbh |
A xanthine derivative as dpp-4 inhibitor for use in the treatment of sirs and/or sepsis
|
|
WO2013174767A1
(en)
|
2012-05-24 |
2013-11-28 |
Boehringer Ingelheim International Gmbh |
A xanthine derivative as dpp -4 inhibitor for use in modifying food intake and regulating food preference
|
|
KR20130140358A
(ko)
|
2012-06-14 |
2013-12-24 |
한미약품 주식회사 |
살메테롤 지나포산염, 플루티카손 프로피오네이트 및 티오트로피움 브로마이드를 포함하는 흡입 제형용 건조 분말 및 이의 제조방법
|
|
KR102391332B1
(ko)
|
2013-03-15 |
2022-04-26 |
펄 테라퓨틱스 인코포레이티드 |
미립자 결정질 재료를 컨디셔닝하는 방법 및 시스템
|
|
EP3110449B1
(en)
|
2014-02-28 |
2023-06-28 |
Boehringer Ingelheim International GmbH |
Medical use of a dpp-4 inhibitor
|
|
GB201408387D0
(en)
*
|
2014-05-12 |
2014-06-25 |
Teva Pharmaceuticals Europ B V |
Treatment of respiratory disorders
|
|
US10034866B2
(en)
|
2014-06-19 |
2018-07-31 |
Teva Branded Pharmaceutical Products R&D, Inc. |
Inhalable medicament comprising tiotropium
|
|
EP4233840A3
(en)
|
2016-06-10 |
2023-10-18 |
Boehringer Ingelheim International GmbH |
Combinations of linagliptin and metformin
|
|
TW201835041A
(zh)
|
2017-02-17 |
2018-10-01 |
印度商托仁特生技有限公司 |
具β-腎上腺素促效劑及抗蕈毒活性化合物
|
|
CN117679423A
(zh)
|
2022-09-05 |
2024-03-12 |
立生医药(苏州)有限公司 |
预防或治疗呼吸系统疾病的吸入用药物组合物
|